Sikhulile Moyo
Zimbabwean virologist From Wikipedia, the free encyclopedia
Sikhulile M. Moyo is a Zimbabwean virologist working as the laboratory director of the Botswana–Harvard AIDS Institute Partnership in Gaborone.[1][2] He is a research associate in immunology and infectious diseases at the Harvard T.H. Chan School of Public Health. In November 2021, Moyo and his laboratory were the first to identify the SARS-CoV-2 Omicron variant. In 2022, Moyo was listed in the Time 100 list.
Sikhulile Moyo | |
|---|---|
| Born | |
| Alma mater | University of Zimbabwe University of Botswana Sefako Makgatho Health Sciences University Stellenbosch University |
| Known for | Moyo and his laboratory were the first to identify the SARS-CoV-2 Omicron variant |
| Children | 3 |
| Scientific career | |
| Fields | Immunology, infectious diseases |
| Institutions | Botswana–Harvard AIDS Institute Partnership Harvard T.H. Chan School of Public Health |
| Thesis | HIV-1C Dynamics and Evolutionary Trends in Botswana |
| Doctoral advisor | Susan Engelbrecht Tulio de Oliveira |
Early life and education
Moyo was born in Zimbabwe.[1] He completed an undergraduate degree at the University of Zimbabwe in 1996.[3] He completed a master's degree in applied microbiology at the University of Botswana in 2000.[3][4] In 2006, Moyo completed a M.P.H. at the University of Limpopo (MEDUNSA-campus). His thesis was titled Modelling the HIV / AIDS in Botswana: the representativeness of the ANC based estimates of HIV prevalence in Botswana and implications for monitoring the epidemic.[5] Moyo completed a Ph.D. in medical virology at Stellenbosch University in 2016. Tulio de Oliveira was one of his professors.[1] His dissertation was titled Evolutionary trends and dynamics of HIV-1C in Botswana.[3]
Career
Moyo joined the Botswana–Harvard AIDS Institute Partnership in 2003 as a lab assistant. He later became the laboratory coordinator, deputy manager, and then lab manager in 2016.[3] As of November 2021, Moyo is the laboratory director. He is also a research associate in immunology and infectious diseases at the Harvard T.H. Chan School of Public Health.[6]
In November 2021, Moyo and his laboratory were the first to identify the SARS-CoV-2 Omicron variant.[7] Upon discovery, they alerted the Botswanan Ministry of Health on November 22, 2021.[8] In 2022, Moyo was listed in the Time 100 list.[9]
Personal life
Moyo is married and has two sons and a daughter.[3] He is a gospel singer and composer.[3]
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.